LB Pharmaceuticals Announces $100M Private Placement with Institutional Investors.

jueves, 5 de febrero de 2026, 8:21 am ET1 min de lectura
LBRX--

LB Pharmaceuticals announces a $100.0 million private placement, selling 3,306,571 shares of common stock and pre-funded warrants to institutional investors. The company plans to use the funds to support its late-stage biopharmaceutical development for schizophrenia, bipolar depression, and other neuropsychiatric diseases.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios